Shike M, Gillin J S, Kemeny N, Daly J M, Kurtz R C
Am J Gastroenterol. 1986 Mar;81(3):176-9.
Patients receiving continuous hepatic artery infusion chemotherapy (HAIC) with 5-fluoro-2'-deoxyuridine for colorectal carcinoma metastatic to the liver frequently complain of nonspecific abdominal discomfort. To determine the etiology of these symptoms we performed upper gastrointestinal endoscopy on symptomatic patients during the course of HAIC. Among 40 patients receiving HAIC of 5-fluoro-2'-deoxyuridine, 21 (53%) developed epigastric pain. They all had upper gastrointestinal endoscopy and 19 were found to have gastroduodenal ulcerations and or erosions. In two patients the infusion catheter eroded into the duodenum. The pathogenesis of the mucosal disease is not clear, but because symptoms responded to discontinuation of HAIC but not to therapy with cimetidine, a direct toxic effect of chemotherapy is postulated. We conclude that patients who complain of upper gastrointestinal symptoms while receiving continuous HAIC with 5-fluoro-2'-deoxyuridine should be investigated for the development of gastroduodenal ulcerations and erosions and that chemotherapy should be withheld if such lesions are found.
接受持续肝动脉灌注化疗(HAIC)并使用5-氟-2'-脱氧尿苷治疗肝转移结直肠癌的患者经常抱怨有非特异性腹部不适。为了确定这些症状的病因,我们在HAIC治疗过程中对有症状的患者进行了上消化道内镜检查。在40例接受5-氟-2'-脱氧尿苷HAIC治疗的患者中,21例(53%)出现上腹部疼痛。他们均接受了上消化道内镜检查,其中19例被发现有胃十二指肠溃疡和/或糜烂。有2例患者的灌注导管侵蚀到十二指肠。黏膜疾病的发病机制尚不清楚,但由于症状在停止HAIC后有所缓解,而使用西咪替丁治疗无效,因此推测为化疗的直接毒性作用。我们得出结论,接受持续HAIC并使用5-氟-2'-脱氧尿苷治疗的患者若出现上消化道症状,应检查是否发生胃十二指肠溃疡和糜烂,若发现此类病变应停止化疗。